Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.74 |
| ▸ | MEN1 | O00255 | 3/20 | 0.74 |
| ▸ | GAA | P10253 | 1/20 | 0.70 |
| ▸ | CA1 | P00915 | 1/20 | 0.67 |
| ▸ | CA2 | P00918 | 1/20 | 0.67 |
| ▸ | CA7 | P43166 | 1/20 | 0.67 |
| ▸ | CA9 | Q16790 | 1/20 | 0.67 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | KDM1A | O60341 | 2/20 | 0.63 |
| ▸ | GRIN2D | O15399 | 4/20 | 0.61 |
| ▸ | GRIN3B | O60391 | 4/20 | 0.61 |
| ▸ | GRIN1 | Q05586 | 4/20 | 0.61 |
| ▸ | GRIN2A | Q12879 | 4/20 | 0.61 |
| ▸ | GRIN2B | Q13224 | 4/20 | 0.61 |
| ▸ | GRIN2C | Q14957 | 4/20 | 0.61 |
| ▸ | GRIN3A | Q8TCU5 | 4/20 | 0.61 |
| ▸ | MAOA | P21397 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11713299 | 1.00 | KMT2A (0.74) | KMT2AMEN1GAACA1CA2 | |
| SCHEMBL7850864 | 0.87 | KMT2A (0.76) | KMT2AMEN1GAACA1CA2 | |
| SCHEMBL28682324 | 0.87 | KMT2A (0.76) | KMT2AMEN1GAACA1CA2 | |
| SCHEMBL16979273 | 0.86 | KMT2A (0.67) | KMT2AMEN1GAACA1CA2 | |
| SCHEMBL11711099 | 0.86 | KMT2A (0.74) | KMT2AMEN1GAACA1CA2 | |
| SCHEMBL30789064 | 0.86 | KMT2A (0.74) | KMT2AMEN1GAACA1CA2 | |
| SCHEMBL15558738 | 0.86 | KMT2A (0.74) | KMT2AMEN1GAACA1CA2 | |
| SCHEMBL24724688 | 0.85 | KMT2A (0.74) | KMT2AMEN1GAACA1CA2 | |
| SCHEMBL14646680 | 0.85 | KMT2A (1.00) | KMT2AMEN1GAACA1CA2 | |
| SCHEMBL7849270 | 0.85 | KMT2A (1.00) | KMT2AMEN1GAACA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220235082-A1 | CATALYSTS | THE UNIVERSITY OF WARWICK (GB) | 2022-07-28 | — | — | US | disclosed |
| WO-2020240178-A1 | CATALYSTS | GoldenKeys High-tech Materials Co., Ltd. (CN) | 2020-12-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220235082-A1 | CATALYSTS | TST, TCP1, CCT3 | KMT2A 3433/4885MEN1 1735/4885GAA 941/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.